0 %

GeneFox
Web-based interpretation software for pharmacogenetic and
genetic-predisposition testing

Import your runs, review a suggested genotype for every sample, and release validated results - with full traceability from analyser to LIS.

GeneFox is a CE-IVDR web-based software that supports the interpretation of molecular results generated with LaCAR pharmacogenetics and genetic-predisposition kits. It captures the run file from your analyser, displays the data in graphical and tabular form, and proposes a suggested genotype for each sample, based on kit-specific criteria. The clinician reviews the curves and validates each result before release. Every action is recorded, and results can be exported in multiple formats or transferred automatically to your laboratory information system.

No installation required - GeneFox runs in your browser.

WHAT IT IS

Regulatory status: CE-IVDR

Type: Web-based In Vitro Diagnostic Medical Device Software

Intended useInterpretation support for pharmacogenetic and genetic-predisposition molecular analysis using LaCAR kits, in professional diagnostic laboratories

Access: Browser-based (Google Chrome, Mozilla Firefox, Edge)

Applications: Drug metabolism & response (TPMT, DPD, CYP2C9, CYP2C19, NUDT15), genetic thrombosis (Factor II, Factor V Leiden, MTHFR, PAI-1), autoimmune (HLA-B27), food intolerance, hemochromatosis

Compatible instruments: real-time PCR platforms (LightCycler 480, Cobas z480, CFX96 / CFX Opus 96, QuantStudio, MIC)

Export formats: PDF, Excel (.xlsx), text (.csv)

LIS integration: Automatic result transfer on approval via SFTP

Traceability: Every interpretation, edit, comment and approval stamped with user, date, time and software version

General information

Key Features

icon convenient
Direct LIS connection
icon sensitivity
Guided genotype interpretation
icon comprehensive
Broad instrument compatibility
icon secure
Intuitive interface and secure data management

Research and Development

Our vision

At LaCAR, we envision a world where everyone benefits from rapid and reliable genetic diagnostics, enabling personalised healthcare while contributing to more equitable and sustainable global public health.

Aware of these challenges, our R&D team is committed to meeting the needs of customers and patients, taking into account the specific recommendations of different countries and continents, as well as advances in academic research and technology.

You have a question regarding our products ? You want to know more about our method ?

Contact